Sailong Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 5/6
Sailong Pharmaceutical GroupLtd has a total shareholder equity of CN¥535.9M and total debt of CN¥137.1M, which brings its debt-to-equity ratio to 25.6%. Its total assets and total liabilities are CN¥813.8M and CN¥278.0M respectively. Sailong Pharmaceutical GroupLtd's EBIT is CN¥11.6M making its interest coverage ratio -35.6. It has cash and short-term investments of CN¥89.3M.
Key information
25.6%
Debt to equity ratio
CN¥137.09m
Debt
Interest coverage ratio | -35.6x |
Cash | CN¥89.26m |
Equity | CN¥535.88m |
Total liabilities | CN¥277.96m |
Total assets | CN¥813.84m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002898's short term assets (CN¥256.3M) exceed its short term liabilities (CN¥227.0M).
Long Term Liabilities: 002898's short term assets (CN¥256.3M) exceed its long term liabilities (CN¥51.0M).
Debt to Equity History and Analysis
Debt Level: 002898's net debt to equity ratio (8.9%) is considered satisfactory.
Reducing Debt: 002898's debt to equity ratio has increased from 0% to 25.6% over the past 5 years.
Debt Coverage: 002898's debt is well covered by operating cash flow (26%).
Interest Coverage: 002898 earns more interest than it pays, so coverage of interest payments is not a concern.